erythromycin has been researched along with virginiamycin in 156 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 60 (38.46) | 18.7374 |
| 1990's | 55 (35.26) | 18.2507 |
| 2000's | 30 (19.23) | 29.6817 |
| 2010's | 10 (6.41) | 24.3611 |
| 2020's | 1 (0.64) | 2.80 |
| Authors | Studies |
|---|---|
| Tsuji, K | 1 |
| de Bethune, MP; Nierhaus, KH | 1 |
| Clewell, DB; Frez, WA; McLellan, TS; Yagi, Y | 1 |
| Cocito, C; Di Giambattista, M | 1 |
| Dublanchet, A; Privitera, G; Sebald, M | 1 |
| Devriese, LA | 1 |
| Malke, H | 1 |
| Jacob, HE; Malke, H; Störl, K | 1 |
| Linnane, AW; Lukins, HB; Molloy, PL; Nagley, P; Sriprakash, KS | 1 |
| Bergmann, R; Hameister, W; Wahlig, H | 1 |
| Bale, MJ; Erwin, ME; Gerlach, EH; Jones, RN; Koontz, FP; Murray, PR; Washington, JA | 1 |
| Appelbaum, PC; Jacobs, MR; Spangler, SK | 1 |
| Chin, NX; Gu, JW; Neu, HC | 1 |
| Chrysos, G; Fraser, HY; Hardie, JM; Maskell, JP; Sefton, AM; Shain, H; Williams, JD | 1 |
| Adam, D | 1 |
| Chin, NX; Neu, HC | 1 |
| Cohen, R; Fremaux, A; Geslin, P; Sissia, G | 1 |
| Goto, S; Kaneko, Y; Miyazaki, S | 1 |
| Brumfitt, W; Hamilton-Miller, JM; Shah, S | 1 |
| Verbist, L; Verhaegen, J | 1 |
| Inoue, K; Inoue, M; Mitsuhashi, S; Okamoto, R; Okubo, T | 1 |
| Dubois, J; Joly, JR | 1 |
| Hoepelman, IM; Verhoef, J | 1 |
| Endou, K; Hashimoto, H; Jánosi, L; Matsuoka, M; Nakajima, Y | 1 |
| Bechhofer, DH; Hue, KK | 1 |
| Hardesty, B; Odom, OW | 1 |
| Catchpole, I; Dyke, KG | 1 |
| Endou, K; Matsuoka, M; Nakajima, Y | 1 |
| Wieckiewicz, J; Wójcik, K | 1 |
| Arora, MK; Felmingham, D; Holton, J; Robbins, MJ | 1 |
| Boussougant, Y; Dubois, S; Weber, P | 1 |
| Denamur, E; Fleuret, A; Laurans, G; Orfila, J; Suermondt, G | 1 |
| Goldman, RC; Kadam, SK | 1 |
| Baker, WR; Fernandes, PB; Freiberg, LA; Hardy, DJ; McDonald, EJ | 1 |
| Berryman, DI; Rood, JI | 1 |
| Barre, J; Deforges, L; Duval, J; Fournet, MP; Tillement, JP; Zini, R | 1 |
| Clewell, DB; Shaw, JH | 1 |
| Dubin, DT; Jenssen, WD; Moon-McDermott, L; Thakker-Varia, S; Weinstein, MP | 1 |
| Lampson, BC; Parisi, JT | 1 |
| Cocito, C; Di Giambattista, M; Jacob, T; Omura, S; Sunazuka, T; Vannuffel, P | 1 |
| Branski, D; Stopler, T | 1 |
| Cocito, C; Di Giambattista, M; Engelborghs, Y; Nyssen, E | 1 |
| Baquero, F; Campello, MG; Reig, M | 1 |
| Maskell, JP; Williams, JD | 1 |
| Boris, K; Brown, D; Katz, L; Tuan, J | 1 |
| Barre, J; Deforges, L; Fournet, MP; Tillement, JP; Zini, R | 1 |
| Chinali, G; Cocito, C; Di Giambattista, M; Nyssen, E | 2 |
| Moazed, D; Noller, HF | 1 |
| Kamimiya, S; Weisblum, B | 1 |
| Chi, SJ; Maskell, JP; Sefton, AM; Williams, JD; Yong, J | 1 |
| Chinali, G; Cocito, C | 1 |
| Beck, D; Siegenthaler, G; Siegenthaler, W; Weidmann, P | 1 |
| Barnum, DA; Hariharan, H | 1 |
| Kubota, K; Okuyama, A; Tanaka, N | 1 |
| Roser, H | 1 |
| Goldmann, SF; Heiss, F | 1 |
| Legler, F | 1 |
| Knoll, KH | 1 |
| Hohenegger, M; Hromadka, A | 1 |
| Fujisawa, Y; Weisblum, B | 1 |
| Dubnau, D | 1 |
| Dubnau, D; Gryczan, TJ; Israeli-Reches, M | 1 |
| Hecht, DW; Lampson, BC; Parisi, JT; Robbins, J | 1 |
| Horinouchi, S; Weisblum, B | 1 |
| Cocito, C; Di Giambattista, M; Engelborghs, Y; Moureau, P | 1 |
| Del Bue, M; Dubnau, D; Gryczan, T; Israeli-Reches, M | 1 |
| Dubnau, D; Israeli-Reches, M; Weinrauch, Y | 1 |
| Callihan, DR; Clark, VL; Young, FE | 1 |
| Weisblum, B | 1 |
| Docherty, A; Dubnau, D; Grandi, G; Grandi, R; Gryczan, TJ; Shivakumar, AG | 1 |
| Dubnau, D; Shivakumar, AG | 1 |
| Cocito, C; Di Giambattista, M; Parfait, R | 1 |
| Bornstein, N; Fleurette, J; Roudier, C | 1 |
| Haefeli, C; Hardy, K | 1 |
| Devriese, LA; Dutta, GN | 2 |
| Drugeon, H; Entenza, JM; Glauser, MP; Moreillon, P | 1 |
| Entenza, JM; Glauser, MP; L'Hériteau, F; Lacassin, F; Leport, C; Moreillon, P | 1 |
| Barry, AL; Fuchs, PC | 1 |
| Appelbaum, PC; Jacobs, MR; Pankuch, GA | 2 |
| Fomina, IP | 1 |
| Bébéar, C; de Barbeyrac, B; Dewilde, A; Edert, D; Janvresse, C; Layani, MP; Le Faou, A; Lefèvre, JC; Mendel, I; Renaudin, H | 1 |
| Auckenthaler, R; Peyret, M; Rohner, P | 1 |
| Dabernat, H; Delmas, C; Seguy, M | 1 |
| Fremaux, A; Geslin, P; Sissia, G | 1 |
| Edelstein, MA; Edelstein, PH | 1 |
| Hof, H; Kretschmar, M; Nichterlein, T | 1 |
| Appelbaum, PC; Jacobs, MR; Lichtenberger, C; Pankuch, GA | 1 |
| Sutcliffe, J; Tait-Kamradt, A; Wondrack, L | 1 |
| Alcaide, F; Carratala, J; Gudiol, F; Liñares, J; Martin, R | 1 |
| Biedenbach, D; Jones, RN; Wanger, A | 1 |
| Baumberg, S; Cove, JH; Eady, EA; Ross, JI | 1 |
| Endou, K; Inoue, M; Kobayashi, H; Matsuoka, M; Nakajima, Y | 1 |
| Houlihan, HH; Kaatz, GW; Mercier, RC; Rybak, MJ | 1 |
| Iino, S; Iwasawa, H; Nakashio, S; Shimada, J | 1 |
| Caron, F; Eliopoulos, GM; Farris, MG; Gold, HS; Moellering, RC; Wennersten, CB | 1 |
| Maskell, JP; Sefton, AM; Whiley, AC; Williams, JD | 1 |
| Jorgensen, JH; McElmeel, ML | 1 |
| Ayestaran, I; Marimon, JM; Montes, M; Perez-Trallero, E; Urbieta, M | 1 |
| Arnold, B; Stout, JE; Yu, VL | 1 |
| Barry, AL; Brown, SD; Fuchs, PC | 2 |
| Bui, MH; Chu, DT; Elliott, RL; Ewing, PJ; Flamm, RK; Griesgraber, G; Henry, RF; Kim, K; Nilius, AM; Or, YS; Pireh, D; Plattner, JJ; Raney, PM | 1 |
| Bui, MH; Chu, DT; Elliott, RL; Ewing, PJ; Flamm, RK; Griesgraber, G; Kramer, MJ; Nilius, AM; Or, YS; Plattner, JJ; Raney, PM | 1 |
| Kresken, M; Lemperle, M; Lütticken, R; Mechery, V; Reinert, RR | 1 |
| Baquero, F; Portillo, A; Ruiz, F; Saenz, Y; Tenorio, C; Torres, C; Zarazaga, M | 1 |
| Giovanetti, E; Mingoia, M; Montanari, MP; Varaldo, PE | 1 |
| Appelbaum, PC; Credito, KL; Ednie, LM; Jacobs, MR | 1 |
| Charbit, Y; Fosse, TB; Hannoun, LR; Hitzig, C; Madinier, IM | 1 |
| Endou, K; Jánosi, L; Matsuoka, M; Nakajima, Y | 1 |
| Gould, FK; Panagea, S; Perry, JD | 1 |
| Gastañares, MJ; Lantero, M; Portillo, A; Ruiz-Larrea, F; Torres, C | 1 |
| Matsuoka, M | 1 |
| Betriu, C; Boloix, A; Culebras, E; Gómez, M; Palau, ML; Picazo, JJ; Redondo, M; Sánchez, A | 1 |
| Lion, C; Lozniewski, A; Mory, F; Weber, M | 1 |
| Auckenthaler, R; Courvalin, P; Féger, C; Roche, G | 1 |
| Foustoukou, M; Ioannidou, S; Kotsovili-Tseleni, A; Legakis, NJ; Tassios, PT; Vatopoulos, A | 1 |
| Bonnefoy, A; Delachaume, C; Girard, AM; Guitton, M; Le Priol, P | 1 |
| Brandt, CM; Bryskier, A; Holland, R; Honscha, M; Hövener, B; Lütticken, R; Reinert, RR; Truong, ND | 1 |
| Almaraz, F; Baquero, F; Cantón, R; Galán, JC; Loza, E; Morosini, MI; Negri, MC | 1 |
| Cartwright, FD; Kenny, GE | 1 |
| Bordi, E; D'Ambrosio, F; Del Grosso, M; Pantosti, A; Scotto D'Abusco, A | 1 |
| Malathum, K; Murray, BE; Singh, KV | 1 |
| Astfalk, N; Jagusch, H; Petridou, J; Scheuring, S; Schmitz, FJ; Schwarz, S | 1 |
| Astfalk, N; Köhrer, K; Petridou, J; Scheuring, S; Schmitz, FJ; Schwarz, S | 1 |
| Chatzidimitriou, M; Katikaridou, E; Kollaras, P; Koumentaki, E; Metallidis, S; Nikolaidis, P; Tourkantonis, A; Tsona, A | 1 |
| Abb, J | 1 |
| Chang, FY; Chuang, YC; Hsueh, PR; Huang, WK; Ko, WC; Lau, YJ; Lee, CM; Leu, HS; Liu, CY; Liu, YC; Lu, JJ; Luh, KT; Shyr, JM; Teng, LJ; Wan, JH; Wu, JJ; Wu, TL; Yan, JJ; Yang, D; Yang, YC | 1 |
| ACAR, JF; CHABBERT, YA | 1 |
| Gfeller, KY; Meile, L; Roth, M; Teuber, M | 1 |
| Andersen, JS; Emborg, HD; Seyfarth, AM; Wegener, HC | 1 |
| Canales, M; Capilla, S; Cerdá Zolezzi, P; Durán, E; Gómez-Lus, R; Goñi, P; Millán, L; Rubio Calvo, MC | 1 |
| Buckley, T; Chapin, A; Gibson, K; Rule, A; Schwab, K | 1 |
| Blaha, G; Moore, PB; Steitz, TA; Tu, D | 1 |
| Arslan, H; Azap, OK; Gagir, U; Oruç, E; Timurkaynak, F; Yapar, G | 1 |
| Kilic, B; Kruse, M; Stahlmann, R | 1 |
| D'Costa, VM; Hughes, DW; McGrann, KM; Wright, GD | 1 |
| Khalifa, OA; Mevius, DJ; Stegeman, JA; Van den Broek, J; Vernooij, JC | 1 |
| Adamkiewicz, T; Miller, ML; Montgomery, J; Obert, CA; Tuomanen, EI | 1 |
| Flick, B; Kilic, B; Kruse, M; Stahlmann, R | 1 |
| Bilewska, A; Luczak, M; Młynarczyk, A; Młynarczyk, G; Pupek, J; Szymanek, K | 1 |
| Choi, EC; Kim, H; Kwon, AR; Shim, MJ; Yoon, EJ; Yoon, JM | 1 |
| Janata, J; Novotná, G; Spízek, J | 1 |
| Aslam, M; Diarra, MS; Rempel, H; Service, C | 1 |
| Brooks, SP; Dandurand, UD; Kalmokoff, M; Letellier, A; Liang, KL; Ma, C; Matias, F; Thomas, M; Topp, E; Waddington, LM | 1 |
| Heist, EP; Moe, LA; Murphree, CA | 1 |
| Avlami, A; Evangelopoulos, A; Hadjisoteriou, M; Petrikkos, G; Vallianou, N | 1 |
| Beall, B; Chochua, S; Hawkins, PA; Jackson, D; McGee, L | 1 |
| Ahn, JW; Baek, YS; Jeon, J; Song, HJ | 1 |
| De Alwis, HG; Duelge, KJ; Nishshanka, U | 1 |
| Bodeis Jones, SM; Domesle, KJ; Gaines, SA; Ge, B; Gilbert, JM; Harbottle, HC; Keller, MW; Li, X; Piñeiro, SA; Rice-Trujillo, CL; Whitney, BM; Yang, Q; Young, SR | 1 |
| Chen, CJ; Chuang, YY; Huang, YC; Ko, WC; Lauderdale, TY; Lee, CY; Lu, CT; Lu, MC; Wu, TS; Yang, CC | 1 |
| Li, B; Lin, C; Ong, EJL; Wang, M; Yi, X; Zhou, Z | 1 |
| Min, YH; Park, B | 1 |
5 review(s) available for erythromycin and virginiamycin
| Article | Year |
|---|---|
Clinical use of the new macrolides, azalides, and streptogramins in pediatrics.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Child; Child, Preschool; Clinical Trials as Topic; Erythromycin; Humans; Infant; Virginiamycin | 1992 |
[New macrolides, azalides and streptogramins; current role and their future perspective].
Topics: Anti-Bacterial Agents; Aza Compounds; Drug Interactions; Erythromycin; Humans; Kidney; Liver; Virginiamycin | 1992 |
Translational attenuation: the regulation of bacterial resistance to the macrolide-lincosamide-streptogramin B antibiotics.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacteria; Bacterial Proteins; Base Sequence; Drug Resistance, Microbial; Enzyme Induction; Erythromycin; Gene Expression Regulation; Genes, Bacterial; Lincosamides; Macrolides; Nucleic Acid Conformation; Operon; Plasmids; Protein Biosynthesis; Ribosomal Proteins; Ribosomes; RNA Processing, Post-Transcriptional; RNA, Bacterial; RNA, Messenger; RNA, Ribosomal; Structure-Activity Relationship; tRNA Methyltransferases; Virginiamycin | 1984 |
Inducible erythromycin resistance in bacteria.
Topics: Bacteria; Bacterial Proteins; Base Sequence; Drug Resistance, Microbial; Erythromycin; Genes, Bacterial; Genes, Regulator; Lincomycin; Methylation; Methyltransferases; Models, Genetic; Mutation; Plasmids; Protein Biosynthesis; RNA, Ribosomal; Site-Specific DNA-Methyltransferase (Adenine-Specific); Virginiamycin | 1984 |
[Study of macrolide, lincosamide, and streptogramin B antibiotics resistance in Staphylococcus aureus].
Topics: Amino Acid Sequence; Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacterial Proteins; Base Sequence; Drug Resistance, Microbial; Erythromycin; Genes, Bacterial; Lincosamides; Macrolides; Membrane Proteins; Molecular Conformation; Molecular Sequence Data; RNA, Bacterial; RNA, Ribosomal, 23S; Staphylococcus aureus; Virginiamycin | 2000 |
151 other study(ies) available for erythromycin and virginiamycin
| Article | Year |
|---|---|
High-pressure liquid chromatography of antibiotics.
Topics: Anti-Bacterial Agents; Bacitracin; Chromatography; Clindamycin; Dactinomycin; Daunorubicin; Erythromycin; Griseofulvin; Hydrocarbons; Kanamycin; Novobiocin; Oxytetracycline; Penicillins; Polymers; Pressure; Rifampin; Tetracycline; Virginiamycin | 1975 |
Characterisation of the binding of virginiamycin S to Escherichia coli ribosomes.
Topics: Binding Sites; Binding, Competitive; Erythromycin; Escherichia coli; Kinetics; Ribosomal Proteins; Ribosomes; Virginiamycin | 1978 |
Characterization of a small plasmid determining resistance to erythromycin, lincomycin, and vernamycin Balpha in a strain of Streptococcus sanguis isolated from dental plaque.
Topics: Anti-Bacterial Agents; Dental Plaque; DNA, Bacterial; Erythromycin; Humans; Lincomycin; R Factors; Streptococcus sanguis; Virginiamycin | 1978 |
The in vitro binding of virginiamycin M to bacteria ribosomes and ribosomal subunits.
Topics: Bacillus subtilis; Binding, Competitive; Chloramphenicol; Cold Temperature; Dose-Response Relationship, Drug; Erythromycin; Escherichia coli; Hot Temperature; Kinetics; Oleandomycin; Ribosomes; Virginiamycin | 1978 |
Transfer of multiple antibiotic resistance between subspecies of Bacteroides fragilis.
Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; Clindamycin; Conjugation, Genetic; Drug Resistance, Microbial; Erythromycin; In Vitro Techniques; Peptides; Plasmids; Rifamycins; Tetracycline; Virginiamycin | 1979 |
In vitro susceptibility and resistance of animal staphylococci to macrolide antibiotics and related compounds.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Erythromycin; Spectinomycin; Staphylococcus aureus; Virginiamycin | 1976 |
Transfer of a plasmid mediating antibiotic resistance between strains of Streptococcus pyogenes in mixed cultures.
Topics: Chromosomes, Bacterial; Drug Resistance, Microbial; Erythromycin; Extrachromosomal Inheritance; Lincomycin; Lysogeny; Plasmids; Streptococcus pyogenes; Streptomycin; Transduction, Genetic; Virginiamycin | 1975 |
Characterization of the antibiotic resistance plasmid ERL1 from Streptococcus pyogenes.
Topics: DNA, Bacterial; Drug Resistance, Microbial; Erythromycin; Extrachromosomal Inheritance; Lincomycin; Molecular Weight; Plasmids; Species Specificity; Streptococcus pyogenes; Virginiamycin | 1976 |
Biogenesis of mitochondria. XLI. Physical mapping of mitochondrial genetic markers in yeast.
Topics: Base Sequence; Chloramphenicol; Chromosome Mapping; DNA, Circular; DNA, Mitochondrial; Drug Resistance, Microbial; Erythromycin; Genotype; Mitochondria; Mutation; Nucleic Acid Hybridization; Oligomycins; Paromomycin; Saccharomyces cerevisiae; Species Specificity; Virginiamycin | 1976 |
Staphylococcal micrococcins. III. Antibacterial and therapeutic properties.
Topics: Animals; Bacitracin; Bacteriocins; Dogs; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Erythromycin; Male; Mice; Microbial Sensitivity Tests; Micrococcaceae; Mycobacterium avium; Mycobacterium tuberculosis; Staphylococcal Infections; Streptococcal Infections; Time Factors; Virginiamycin | 1975 |
MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycin.
Topics: Anti-Bacterial Agents; Cefdinir; Cefpirome; Ceftibuten; Ceftizoxime; Cephalosporins; Clarithromycin; Erythromycin; Fleroxacin; Fluoroquinolones; Haemophilus; Humans; Microbial Sensitivity Tests; Quality Control; Quinolones; Spectinomycin; Virginiamycin | 1992 |
Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Quinolones; Streptococcus pneumoniae; Vancomycin; Virginiamycin | 1992 |
The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combination.
Topics: Azithromycin; Bacteria; Cefotaxime; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Erythromycin; Gentamicins; Gram-Negative Bacteria; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Miocamycin; Roxithromycin; Virginiamycin | 1992 |
Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteria; Bacteria, Anaerobic; Erythromycin; Microbial Sensitivity Tests; Mouth; Streptococcus; Virginiamycin | 1992 |
Post-antibiotic effect of the new streptogramin RP 59500.
Topics: Clindamycin; Drug Resistance, Microbial; Erythromycin; Evaluation Studies as Topic; Microbial Sensitivity Tests; Oxacillin; Staphylococcus; Streptococcus; Time Factors; Virginiamycin | 1992 |
In-vitro antibacterial activity of RP 59500, a semisynthetic streptogramin, against Streptococcus pneumoniae.
Topics: Erythromycin; In Vitro Techniques; Microbial Sensitivity Tests; Streptococcus pneumoniae; Virginiamycin | 1992 |
The in-vitro activity of RP 59500 against gram-positive cocci.
Topics: Amoxicillin; Ciprofloxacin; Erythromycin; Gram-Positive Cocci; In Vitro Techniques; Josamycin; Methicillin Resistance; Microbial Sensitivity Tests; Vancomycin; Virginiamycin | 1992 |
In-vitro activity of RP 59500, a new semisynthetic streptogramin antibiotic, against gram-positive bacteria.
Topics: Erythromycin; Gram-Positive Bacteria; In Vitro Techniques; Microbial Sensitivity Tests; Virginiamycin | 1992 |
Comparative in-vitro activity of RP 59500.
Topics: Bacteria; Ciprofloxacin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Gentamicins; In Vitro Techniques; Microbial Sensitivity Tests; Oxacillin; Vancomycin; Virginiamycin | 1992 |
Comparative in-vitro activity of RP 59500 against clinical bacterial isolates.
Topics: Ampicillin; Cefotaxime; Erythromycin; Gram-Positive Cocci; Humans; In Vitro Techniques; Methicillin Resistance; Microbial Sensitivity Tests; Virginiamycin | 1992 |
In-vitro activity of RP 59500, a new synergic antibacterial agent, against Legionella spp.
Topics: Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Erythromycin; Humans; In Vitro Techniques; Legionella; Microbial Sensitivity Tests; Respiratory Tract Infections; Rifampin; Virginiamycin | 1992 |
Inducible resistance to a 16-membered macrolide, mycinamicin, in Staphylococcus aureus resistant to 14-membered macrolides and streptogramin B antibiotics.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Erythromycin; Macrolides; Oleandomycin; Staphylococcus aureus; Virginiamycin | 1992 |
Regulation of the macrolide-lincosamide-streptogramin B resistance gene ermD.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacillus subtilis; Base Sequence; Codon; DNA Mutational Analysis; Drug Resistance, Microbial; Erythromycin; Gene Expression Regulation, Bacterial; Methyltransferases; Molecular Sequence Data; Nucleic Acid Conformation; Protein Biosynthesis; Protein Sorting Signals; Recombinant Fusion Proteins; Regulatory Sequences, Nucleic Acid; Transcription, Genetic; Virginiamycin | 1992 |
Use of 50 S-binding antibiotics to characterize the ribosomal site to which peptidyl-tRNA is bound.
Topics: Anti-Bacterial Agents; Binding Sites; Erythromycin; Escherichia coli; In Vitro Techniques; Lincomycin; Puromycin; Ribosomes; RNA, Transfer, Amino Acyl; Sparsomycin; Virginiamycin | 1992 |
A Staphylococcus aureus plasmid that specifies constitutive macrolide-lincosamide-streptogramin B resistance contains a novel deletion in the ermC attenuator.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; DNA, Bacterial; Drug Resistance, Microbial; Erythromycin; Gene Expression Regulation, Bacterial; Genes, Bacterial; Lincosamides; Macrolides; Molecular Sequence Data; Mutation; Nucleic Acid Conformation; R Factors; Staphylococcus aureus; Virginiamycin | 1990 |
Localization of a determinant mediating partial macrolide resistance in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; DNA, Bacterial; Drug Resistance, Microbial; Erythromycin; Humans; Lincosamides; Macrolides; Plasmids; Staphylococcal Infections; Staphylococcus aureus; Transduction, Genetic; Virginiamycin | 1990 |
Stability and expression of the staphylococcal constitutive macrolide-lincosamide-streptogramin B resistance plasmid pE3692 in Staphylococcus aureus and Bacillus subtilis.
Topics: Anti-Bacterial Agents; Bacillus subtilis; Clindamycin; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Agar Gel; Erythromycin; Kinetics; Leucomycins; Lincomycin; Lincosamides; Macrolides; R Factors; Restriction Mapping; Staphylococcus aureus; Virginiamycin | 1989 |
In-vitro activity of the streptogramin group of antimicrobials against Corynebacterium jeikeium and D2 coryneform bacteria.
Topics: Clindamycin; Corynebacterium; Drug Resistance, Microbial; Erythromycin; Microbial Sensitivity Tests; Virginiamycin | 1989 |
In-vitro activity of pristinamycin and its components against gram-negative anaerobic bacilli and Gardnerella vaginalis.
Topics: Anti-Bacterial Agents; Bacteroides fragilis; Clindamycin; Erythromycin; Fusobacterium; Gardnerella vaginalis; Gram-Negative Anaerobic Bacteria; Haemophilus; Microbial Sensitivity Tests; Peptides, Cyclic; Virginiamycin | 1989 |
[In vitro activity of miocamycin compared with four other macrolides and with pristinamycin against Branhamella catarrhalis].
Topics: Anti-Bacterial Agents; Erythromycin; Humans; Leucomycins; Microbial Sensitivity Tests; Miocamycin; Moraxella catarrhalis; Mutagens; Virginiamycin | 1989 |
Binding of novel macrolide structures to macrolides-lincosamides-streptogramin B-resistant ribosomes inhibits protein synthesis and bacterial growth.
Topics: Anti-Bacterial Agents; Bacillus subtilis; Bacteria; Bacterial Proteins; Depression, Chemical; Drug Resistance, Microbial; Erythromycin; Lincosamides; Macrolides; Microbial Sensitivity Tests; Plasmids; Ribosomes; Streptococcus pyogenes; Virginiamycin | 1989 |
New macrolides active against Streptococcus pyogenes with inducible or constitutive type of macrolide-lincosamide-streptogramin B resistance.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Leucomycins; Lincosamides; Macrolides; Molecular Structure; Streptococcus pyogenes; Virginiamycin | 1989 |
Cloning and hybridization analysis of ermP, a macrolide-lincosamide-streptogramin B resistance determinant from Clostridium perfringens.
Topics: Anti-Bacterial Agents; Blotting, Southern; Cloning, Molecular; Clostridium perfringens; DNA Probes; DNA, Bacterial; Drug Resistance, Microbial; Erythromycin; Genes, Bacterial; Lincosamides; Macrolides; Nucleic Acid Hybridization; Virginiamycin | 1989 |
Binding parameters and microbiological activity of macrolides, lincosamides and streptogramins against Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Erythromycin; Lincosamides; Macrolides; Staphylococcus aureus; Tritium; Virginiamycin | 1987 |
Complete nucleotide sequence of macrolide-lincosamide-streptogramin B-resistance transposon Tn917 in Streptococcus faecalis.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; Cloning, Molecular; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Microbial; Enterococcus faecalis; Erythromycin; Lincosamides; Macrolides; Nucleic Acid Conformation; Nucleotidyltransferases; Promoter Regions, Genetic; Repetitive Sequences, Nucleic Acid; Terminator Regions, Genetic; Transposases; tRNA Methyltransferases; Virginiamycin | 1985 |
Molecular epidemiology of macrolides-lincosamides-streptogramin B resistance in Staphylococcus aureus and coagulase-negative staphylococci.
Topics: Anti-Bacterial Agents; Clindamycin; Coagulase; DNA Restriction Enzymes; DNA Transposable Elements; Drug Resistance, Microbial; Erythromycin; Genes, Bacterial; Nucleic Acid Hybridization; Plasmids; Staphylococcus; Staphylococcus aureus; Virginiamycin | 1987 |
Nucleotide sequence of the constitutive macrolide-lincosamide-streptogramin B resistance plasmid pNE131 from Staphylococcus epidermidis and homologies with Staphylococcus aureus plasmids pE194 and pSN2.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; DNA, Bacterial; Drug Resistance, Microbial; Erythromycin; Lincosamides; Macrolides; R Factors; Sequence Homology, Nucleic Acid; Species Specificity; Staphylococcus aureus; Staphylococcus epidermidis; Virginiamycin | 1986 |
Antagonistic interactions of macrolides and synergimycins on bacterial ribosomes.
Topics: Bacteria; Binding, Competitive; Erythromycin; Kinetics; Leucomycins; Microbial Sensitivity Tests; Ribosomes; Virginiamycin | 1986 |
Resistance of Mycoplasma pneumoniae to macrolides, lincomycin and streptogramin B.
Topics: Acridine Orange; Anti-Bacterial Agents; Drug Resistance, Microbial; Erythromycin; Leucomycins; Lincomycin; Microbial Sensitivity Tests; Mycoplasma pneumoniae; Oleandomycin; Virginiamycin | 1986 |
Kinetics of binding of macrolides, lincosamides, and synergimycins to ribosomes.
Topics: Erythromycin; Kinetics; Leucomycins; Lincomycin; Ribosomes; Structure-Activity Relationship; Virginiamycin | 1987 |
Inducible macrolides-lincosamides-streptogramin B resistance in Bacteroides species.
Topics: Anti-Bacterial Agents; Bacteroides; Clindamycin; Drug Resistance, Microbial; Erythromycin; Gene Expression Regulation; Lincosamides; Macrolides; Microbial Sensitivity Tests; Species Specificity; Virginiamycin | 1987 |
In-vitro susceptibility of oral streptococci to pristinamycin.
Topics: Amoxicillin; Anti-Bacterial Agents; Erythromycin; Humans; Microbial Sensitivity Tests; Mouth; Peptides; Streptococcus; Vancomycin; Virginiamycin | 1987 |
Expression of the macrolide-lincosamide-streptogramin-B-resistance methylase gene, ermE, from Streptomyces erythraeus in Escherichia coli results in N6-monomethylation and N6,N6-dimethylation of ribosomal RNA.
Topics: Adenine; Anti-Bacterial Agents; Drug Resistance, Microbial; Erythromycin; Escherichia coli; Fungal Proteins; Lincosamides; Macrolides; Methylation; Recombinant Fusion Proteins; Recombinant Proteins; RNA, Ribosomal; RNA, Ribosomal, 23S; Streptomyces; tRNA Methyltransferases; Virginiamycin | 1987 |
Binding studies of macrolides, lincosamides and streptogramins to Streptococcus G group using [3H]-erythromycin.
Topics: Anti-Bacterial Agents; Erythromycin; Kinetics; Lincosamides; Macrolides; Microbial Sensitivity Tests; Streptococcus; Tritium; Virginiamycin | 1987 |
Inhibition of polypeptide synthesis in cell-free systems by virginiamycin S and erythromycin. Evidence for a common mode of action of type B synergimycins and 14-membered macrolides.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Erythromycin; Escherichia coli; Kinetics; Protein Biosynthesis; Ribosomes; Structure-Activity Relationship; Virginiamycin | 1988 |
Chloramphenicol, erythromycin, carbomycin and vernamycin B protect overlapping sites in the peptidyl transferase region of 23S ribosomal RNA.
Topics: Acyltransferases; Anti-Bacterial Agents; Autoradiography; Base Sequence; Chloramphenicol; Erythromycin; Escherichia coli; Leucomycins; Nucleic Acid Conformation; Peptidyl Transferases; RNA, Ribosomal; RNA, Ribosomal, 23S; Virginiamycin | 1987 |
Translational attenuation control of ermSF, an inducible resistance determinant encoding rRNA N-methyltransferase from Streptomyces fradiae.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Microbial; Erythromycin; Gene Expression Regulation; Genes, Bacterial; Leucomycins; Lincosamides; Macrolides; Methyltransferases; Molecular Sequence Data; Mutation; Phenotype; Protein Biosynthesis; Protein Sorting Signals; Streptomyces; Transcription, Genetic; Virginiamycin | 1988 |
Action of erythromycin and virginiamycin S on polypeptide synthesis in cell-free systems.
Topics: Erythromycin; Escherichia coli; GTP Phosphohydrolase-Linked Elongation Factors; Guanosine Triphosphate; Peptide Biosynthesis; Peptide Chain Elongation, Translational; Peptide Elongation Factor G; Peptide Elongation Factor Tu; Peptide Elongation Factors; Poly A; Poly C; Poly U; Puromycin; Ribosomes; RNA, Transfer, Amino Acyl; Virginiamycin | 1988 |
Comparative in-vitro activity of erythromycin, vancomycin and pristinamycin.
Topics: Bacteria; Enterobacteriaceae; Erythromycin; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus; Vancomycin; Virginiamycin | 1988 |
Molecular mechanism of action of virginiamycin-like antibiotics (synergimycins) on protein synthesis in bacterial cell-free systems.
Topics: Bacteria; Cations, Divalent; Cations, Monovalent; Cell-Free System; Erythromycin; Kinetics; Protein Biosynthesis; Ribosomes; RNA, Transfer, Amino Acyl; Structure-Activity Relationship; Virginiamycin | 1985 |
[New antibiotics, with the exception of penicillins, streptomycin, tetracyclines and chloramphenicol].
Topics: Anti-Bacterial Agents; Cephalosporins; Chemistry, Pharmaceutical; Erythromycin; Fusidic Acid; Gentamicins; Kanamycin; Leucomycins; Lincomycin; Neomycin; Novobiocin; Oleandomycin; Paromomycin; Polymyxins; Rifampin; Ristocetin; Spectinomycin; Vancomycin; Virginiamycin | 1968 |
Minimal inhibitory concentrations of twenty antimicrobial agents to animal pathogens.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria; Cephaloridine; Chloramphenicol; Cloxacillin; Erythromycin; Escherichia coli; Framycetin; Gentamicins; Kanamycin; Leucomycins; Lincomycin; Methicillin; Microbial Sensitivity Tests; Nalidixic Acid; Novobiocin; Oleandomycin; Penicillin Resistance; Penicillins; Polymyxins; Pseudomonas aeruginosa; Salmonella typhimurium; Spectinomycin; Staphylococcus; Virginiamycin | 1974 |
Differential effects of antibiotics on peptidyl transferase reactions.
Topics: Anti-Bacterial Agents; Depression, Chemical; Erythromycin; Escherichia coli; Leucomycins; Peptide Biosynthesis; Peptide Chain Elongation, Translational; Puromycin; Ribosomes; Transferases; Virginiamycin | 1972 |
[Determination of resistance to the antibiotic staphylomycin].
Topics: Anti-Bacterial Agents; Chloramphenicol; Cloxacillin; Erythromycin; Fusidic Acid; Methicillin; Neomycin; Oxacillin; Penicillin Resistance; Penicillins; Staphylococcus; Streptomycin; Tetracycline; Virginiamycin | 1966 |
[The phenomenom of resistance and cross resistance to erythromycin, lincomycin and staphylomycin].
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Erythromycin; Lincomycin; Microbial Sensitivity Tests; Staphylococcus; Virginiamycin | 1971 |
[Present resistance status of Staphylococcus aureus under specific consideration of the antibiotics virgimycia, cephalothin and fusidic acid].
Topics: Adult; Ampicillin; Animals; Anti-Bacterial Agents; Bacitracin; Cephalothin; Child; Chloramphenicol; Erythromycin; Fusidic Acid; Humans; Neomycin; Nitrofurantoin; Oleandomycin; Penicillin G; Penicillin Resistance; Penicillin V; Staphylococcus; Streptomycin; Sulfonamides; Tetracycline; Virginiamycin | 1967 |
[Sensitivity of Staphylococci and enterococci to staphylomycin with special consideration of urine-bacteria].
Topics: Anti-Bacterial Agents; Bacteriuria; Bile; Chloramphenicol; Enterococcus faecalis; Erythromycin; Fusidic Acid; Humans; Immunodiffusion; Kanamycin; Oxacillin; Penicillin G; Penicillin Resistance; Sputum; Staphylococcus; Suppuration; Tetracycline; Virginiamycin | 1969 |
[Sensitivity of staphylococci to antibiotics].
Topics: Ampicillin; Anti-Bacterial Agents; Cephalothin; Chloramphenicol; Chlortetracycline; Culture Media; Erythromycin; Kanamycin; Methicillin; Oxytetracycline; Penicillin G; Penicillin Resistance; Rifampin; Staphylococcus; Streptomycin; Vancomycin; Virginiamycin | 1966 |
A family of r-determinants in Streptomyces spp. that specifies inducible resistance to macrolide, lincosamide, and streptogramin type B antibiotics.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Erythromycin; Leucomycins; Methylation; RNA, Bacterial; RNA, Ribosomal; Species Specificity; Streptomyces; Virginiamycin | 1981 |
Induction of macrolide-lincosamide-streptogramin B resistance requires ribosomes able to bind inducer.
Topics: Anti-Bacterial Agents; Bacillus; Bacterial Proteins; Enzyme Induction; Erythromycin; Genes, Bacterial; Lincosamides; Macrolides; R Factors; Ribosomes; RNA, Bacterial; RNA, Ribosomal; Staphylococcus aureus; tRNA Methyltransferases; Virginiamycin | 1984 |
Characterization of a macrolide, lincosamide, and streptogramin resistance plasmid in Staphylococcus epidermidis.
Topics: Anti-Bacterial Agents; DNA Restriction Enzymes; Erythromycin; Lincosamides; Macrolides; Nucleic Acid Hybridization; R Factors; Staphylococcus; Staphylococcus aureus; Transduction, Genetic; Virginiamycin | 1981 |
Nucleotide sequence and functional map of pE194, a plasmid that specifies inducible resistance to macrolide, lincosamide, and streptogramin type B antibodies.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; Chloramphenicol; Deoxyribonucleases, Type II Site-Specific; DNA Replication; DNA Restriction Enzymes; Erythromycin; Gene Expression Regulation; Mutation; Peptides; R Factors; Staphylococcus aureus; Virginiamycin | 1982 |
Fluorescence stopped flow analysis of the interaction of virginiamycin components and erythromycin with bacterial ribosomes.
Topics: Erythromycin; Escherichia coli; Fluorometry; Kinetics; Mathematics; Ribosomes; Virginiamycin | 1983 |
DNA sequence and regulation of ermD, a macrolide-lincosamide-streptogramin B resistance element from Bacillus licheniformis.
Topics: Anti-Bacterial Agents; Bacillus; Bacterial Proteins; Base Sequence; DNA, Bacterial; Enzyme Induction; Erythromycin; Genes, Bacterial; Lincosamides; Macrolides; Operon; R Factors; tRNA Methyltransferases; Virginiamycin | 1984 |
Evolutionary relationships of the Bacillus licheniformis macrolide-lincosamide-streptogramin B resistance elements.
Topics: Anti-Bacterial Agents; Bacillus; Bacterial Proteins; Biological Evolution; DNA, Bacterial; Drug Resistance, Microbial; Erythromycin; Lincosamides; Macrolides; R Factors; Species Specificity; Streptomyces; tRNA Methyltransferases; Virginiamycin | 1984 |
Presence of two unique genes encoding macrolide-lincosamide-streptogramin resistance in members of the Bacteroides fragilis group as determined by DNA-DNA homology.
Topics: Bacteroides fragilis; Base Sequence; Clindamycin; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Agar Gel; Erythromycin; Nucleic Acid Hybridization; R Factors; Virginiamycin | 1984 |
Naturally occurring macrolide-lincosamide-streptogramin B resistance in Bacillus licheniformis.
Topics: Anti-Bacterial Agents; Bacillus; Bacterial Proteins; Cloning, Molecular; Drug Resistance, Microbial; Erythromycin; Genes; Nucleic Acid Hybridization; Plasmids; Virginiamycin | 1981 |
Characterization of a plasmid-specified ribosome methylase associated with macrolide resistance.
Topics: Amino Sugars; Anti-Bacterial Agents; Bacillus subtilis; Drug Resistance, Microbial; Erythromycin; Mutation; Plasmids; Ribosomes; Species Specificity; tRNA Methyltransferases; Virginiamycin | 1981 |
Competition between erythromycin and virginiamycin for in vitro binding to the large ribosomal subunit.
Topics: Binding Sites; Binding, Competitive; Erythromycin; Escherichia coli; In Vitro Techniques; Ribosomes; Virginiamycin | 1981 |
[Practical problems raised by antibiotic minimal inhibitory concentration determination in Legionella species (author's transl)].
Topics: Anti-Bacterial Agents; Cefoxitin; Chloramphenicol; Culture Media; Erythromycin; Legionella; Microbial Sensitivity Tests; Rifampin; Virginiamycin | 1982 |
Expression in Escherichia coli of a staphylococcal gene for resistance to macrolide, lincosamide, and streptogramin type B antibiotics.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Clindamycin; DNA, Recombinant; Erythromycin; Escherichia coli; Genes, Bacterial; R Factors; Staphylococcus aureus; Transformation, Bacterial; Virginiamycin | 1982 |
Resistance to macrolide-lincosamide-streptogramin antibiotics in enterococci from the intestines of animals.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cecum; Clindamycin; Drug Resistance, Microbial; Enterococcus faecalis; Erythromycin; Leucomycins; Lincomycin; Lincosamides; Macrolides; Oleandomycin; Poultry; Streptococcus; Swine; Virginiamycin | 1982 |
Resistance to macrolide, lincosamide and streptogramin antibiotics and degradation of lincosamide antibiotics in streptococci from bovine mastitis.
Topics: Animals; Anti-Bacterial Agents; Cattle; Clindamycin; Drug Resistance, Microbial; Erythromycin; Female; Lincomycin; Mastitis, Bovine; Streptococcus; Virginiamycin | 1982 |
Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500.
Topics: Animals; Drug Resistance, Microbial; Endocarditis, Bacterial; Erythromycin; Female; Methicillin Resistance; Microbial Sensitivity Tests; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virginiamycin | 1995 |
RP 59500 prophylaxis of experimental endocarditis due to erythromycin-susceptible and -resistant isogenic pairs of viridans group streptococci.
Topics: Animals; Conjugation, Genetic; Drug Resistance, Microbial; Endocarditis, Bacterial; Erythromycin; Female; Microbial Sensitivity Tests; Rats; Rats, Wistar; Streptococcal Infections; Streptococcus; Vancomycin; Virginiamycin | 1995 |
In vitro activities of a streptogramin (RP59500), three macrolides, and an azalide against four respiratory tract pathogens.
Topics: Erythromycin; Haemophilus influenzae; Microbial Sensitivity Tests; Moraxella catarrhalis; Streptococcus; Virginiamycin | 1995 |
Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology.
Topics: Anti-Infective Agents; Ciprofloxacin; Erythromycin; Fluoroquinolones; Kinetics; Microbial Sensitivity Tests; Penicillin G; Quinolones; Streptococcus pneumoniae; Time Factors; Vancomycin; Virginiamycin | 1994 |
[Second international conference on macrolides, azalides and streptogramins (Venice, Italy, January 19-22, 1994)].
Topics: Anti-Bacterial Agents; Erythromycin; Microbial Sensitivity Tests; Structure-Activity Relationship; Virginiamycin | 1994 |
[Multicenter study of the in vitro sensitivity of genital mycoplasmas to antibiotics].
Topics: Clindamycin; Doxycycline; Drug Resistance, Microbial; Erythromycin; Female; Humans; In Vitro Techniques; Josamycin; Lymecycline; Male; Minocycline; Mycoplasma; Ofloxacin; Ureaplasma urealyticum; Virginiamycin | 1993 |
Determination of MICs for staphylococci using the API ATB quinolone and API ATB macrolide systems.
Topics: Ciprofloxacin; Clindamycin; Dose-Response Relationship, Drug; Erythromycin; Humans; In Vitro Techniques; Lincomycin; Microbiological Techniques; Nalidixic Acid; Ofloxacin; Pefloxacin; Staphylococcus; Virginiamycin | 1993 |
[Study of susceptibility of Haemophilus influenzae to antibiotics (other than beta-lactams) by using HTM gelose (Haemophilus test medium)].
Topics: Anti-Bacterial Agents; beta-Lactamases; Chloramphenicol; Drug Resistance, Microbial; Erythromycin; Haemophilus influenzae; Immunodiffusion; In Vitro Techniques; Tetracyclines; Trimethoprim; Virginiamycin | 1993 |
[In vitro antibacterial activity of pristinamycin against penicillin resistant Streptococcus pneumoniae].
Topics: Dose-Response Relationship, Drug; Drug Resistance, Microbial; Erythromycin; Humans; In Vitro Techniques; Otitis Media; Penicillin G; Penicillin Resistance; Streptococcal Infections; Streptococcus pneumoniae; Virginiamycin | 1993 |
In vitro activity of RP 74501-RP 74502, a novel streptogramin antimicrobial mixture, against clinical isolates of Legionella species.
Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Erythromycin; Guinea Pigs; Legionella; Legionellosis; Macrophages, Alveolar; Virginiamycin | 1993 |
RP 59500, a streptogramin derivative, is effective in murine listeriosis.
Topics: Animals; Anti-Bacterial Agents; Erythromycin; In Vitro Techniques; Listeria monocytogenes; Mice; Microbial Sensitivity Tests; Virginiamycin | 1996 |
Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Erythromycin; Fluoroquinolones; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Penicillins; Quinolones; Streptococcus pneumoniae; Time Factors; Virginiamycin | 1996 |
Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system.
Topics: Anti-Bacterial Agents; Clindamycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Erythromycin; Methyltransferases; Microbial Sensitivity Tests; Phenotype; Streptococcus pneumoniae; Streptococcus pyogenes; Virginiamycin | 1996 |
MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Clarithromycin; Erythromycin; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Penicillins; Streptococcus pneumoniae; Time Factors; Virginiamycin | 1996 |
In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Erythromycin; Humans; Microbial Sensitivity Tests; Neoplasms; Neutropenia; Penicillin Resistance; Streptococcal Infections; Streptococcus; Virginiamycin | 1996 |
Comparative in-vitro activity of quinupristin/dalfopristin (RP 59500) tested against penicillin-and macrolide-resistant pneumococci by the Etest.
Topics: Anti-Bacterial Agents; Clindamycin; Drug Resistance, Microbial; Drug Synergism; Erythromycin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Rifampin; Streptococcus pneumoniae; Sulfamethoxazole; Trimethoprim; Virginiamycin | 1996 |
Minimal functional system required for expression of erythromycin resistance by msrA in Staphylococcus aureus RN4220.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carrier Proteins; Chromosomes, Bacterial; Crossing Over, Genetic; Drug Resistance, Microbial; Erythromycin; Gene Expression Regulation, Bacterial; Membrane Proteins; Membrane Transport Proteins; Phenotype; Sequence Deletion; Staphylococcus aureus; Virginiamycin | 1996 |
A dyadic plasmid that shows MLS and PMS resistance in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Clindamycin; Drug Resistance, Microbial; Erythromycin; Genes, Bacterial; Genotype; Lincosamides; Macrolides; Oleandomycin; Plasmids; Polymerase Chain Reaction; Ribosomes; Staphylococcus aureus; Virginiamycin | 1997 |
Pharmacodynamics of RP 59500 (quinupristin-dalfopristin) administered by intermittent versus continuous infusion against Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model.
Topics: Anti-Bacterial Agents; Blood Coagulation; Blood Platelets; Drug Administration Schedule; Drug Resistance, Microbial; Erythromycin; Fibrin; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Virginiamycin | 1997 |
[Comparative antimicrobial activity of RP 59,500 (quinupristin-dalfopristin), the first semisynthetic injectable streptgramin, against gram-positive cocci and other recent clinical pathogens].
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Enterococcus; Erythromycin; Gram-Positive Cocci; Humans; Methicillin Resistance; Roxithromycin; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pneumoniae; Streptococcus pyogenes; Virginiamycin | 1997 |
Influence of erythromycin resistance, inoculum growth phase, and incubation time on assessment of the bactericidal activity of RP 59500 (quinupristin-dalfopristin) against vancomycin-resistant Enterococcus faecium.
Topics: Anti-Bacterial Agents; Cell Cycle; Drug Resistance, Microbial; Enterococcus faecium; Erythromycin; Microbial Sensitivity Tests; Time Factors; Vancomycin; Virginiamycin | 1997 |
Comparative in-vitro activity of quinupristin/dalfopristin against Enterococcus spp.
Topics: Amoxicillin; Anti-Bacterial Agents; Enterococcus; Erythromycin; Humans; Microbial Sensitivity Tests; Teicoplanin; Vancomycin; Virginiamycin | 1997 |
Activity of quinupristin/dalfopristin and its components against Haemophilus influenzae.
Topics: Ampicillin; Anti-Bacterial Agents; Culture Media; Erythromycin; Haemophilus influenzae; Microbial Sensitivity Tests; Penicillins; Virginiamycin | 1997 |
Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain.
Topics: Agglutination; Anti-Bacterial Agents; Clindamycin; Drug Resistance, Microbial; Drug Utilization; Erythromycin; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Phylogeny; Polymerase Chain Reaction; Spain; Streptococcus pyogenes; Virginiamycin | 1998 |
Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL-60 cells.
Topics: Anti-Bacterial Agents; Azithromycin; Cell Line; Clarithromycin; Erythromycin; HL-60 Cells; Humans; Legionella; Legionella pneumophila; Macrolides; Microbial Sensitivity Tests; Monocytes; Roxithromycin; Virginiamycin | 1998 |
Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin).
Topics: Anti-Bacterial Agents; Clindamycin; Erythromycin; Humans; Ketolides; Macrolides; Penicillin Resistance; Phenotype; Pneumococcal Infections; Streptococcus pneumoniae; Virginiamycin | 1998 |
Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analogues.
Topics: Animals; Anti-Bacterial Agents; Carbamates; Clarithromycin; Colony Count, Microbial; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Drug Resistance, Multiple; Erythromycin; Haemophilus influenzae; Lincosamides; Macrolides; Mice; Molecular Conformation; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship; Virginiamycin | 1998 |
Anhydrolide macrolides. 2. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbazate erythromycin A analogues.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Drug Resistance, Multiple; Erythromycin; Lincosamides; Macrolides; Mice; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship; Virginiamycin | 1998 |
In vitro activity of quinupristin/dalfopristin against erythromycin-susceptible and erythromycin-resistant Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Clindamycin; Drug Resistance, Microbial; Drug Therapy, Combination; Erythromycin; Humans; Kinetics; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Penicillins; Streptococcus pneumoniae; Virginiamycin | 1998 |
In vitro activity of the new ketolide HMR3647 in comparison with those of macrolides and pristinamycins against Enterococcus spp.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Erythromycin; Ketolides; Macrolides; Microbial Sensitivity Tests; Phenotype; Virginiamycin | 1998 |
Susceptibility to RPR 106,972, quinupristin/dalfopristin and erythromycin among recent clinical isolates of enterococci, staphylococci and streptococci from North American medical centres.
Topics: Academic Medical Centers; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Erythromycin; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; North America; Staphylococcus; Streptococcus; Virginiamycin | 1998 |
Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains.
Topics: Anti-Bacterial Agents; Child; Chloramphenicol; Drug Resistance, Microbial; Drug Resistance, Multiple; Erythromycin; Genotype; Humans; Lincosamides; Macrolides; Microbial Sensitivity Tests; Phenotype; Streptococcus pyogenes; Tetracycline; Virginiamycin | 1999 |
Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Bacteria, Anaerobic; beta-Lactamases; Clarithromycin; Clindamycin; Drug Therapy, Combination; Erythromycin; Gram-Negative Anaerobic Bacteria; Gram-Positive Bacteria; Ketolides; Macrolides; Metronidazole; Microbial Sensitivity Tests; Roxithromycin; Virginiamycin | 1999 |
Resistance profile survey of 50 periodontal strains of Actinobacillus actinomyectomcomitans.
Topics: Adult; Aggregatibacter actinomycetemcomitans; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Ciprofloxacin; Drug Resistance, Microbial; Erythromycin; Humans; Metronidazole; Microbial Sensitivity Tests; Ornidazole; Periodontal Pocket; Periodontitis; Species Specificity; Spiramycin; Tetracycline; Virginiamycin | 1999 |
Cloning and sequences of inducible and constitutive macrolide resistance genes in Staphylococcus aureus that correspond to an ABC transporter.
Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Base Sequence; Cloning, Molecular; Drug Resistance, Microbial; Drug Resistance, Multiple; Erythromycin; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Promoter Regions, Genetic; Restriction Mapping; Sequence Alignment; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus aureus; Virginiamycin | 1999 |
Should clindamycin be used as treatment of patients with infections caused by erythromycin-resistant staphylococci?
Topics: Anti-Bacterial Agents; Clindamycin; Drug Resistance, Microbial; Erythromycin; Humans; Lincosamides; Macrolides; Microbial Sensitivity Tests; Staphylococcal Infections; Virginiamycin | 1999 |
Macrolide resistance phenotypes and mechanisms of resistance in Streptococcus pyogenes in La Rioja, Spain.
Topics: Anti-Bacterial Agents; DNA-Binding Proteins; Drug Resistance, Microbial; Drug Resistance, Multiple; Erythromycin; Humans; Lincosamides; Macrolides; Microbial Sensitivity Tests; Polymerase Chain Reaction; Spain; Streptococcus pyogenes; Transcription Factors; Virginiamycin | 1999 |
Comparative in vitro activities of linezolid, quinupristin-dalfopristin, moxifloxacin, and trovafloxacin against erythromycin-susceptible and -resistant streptococci.
Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Microbial; Drug Therapy, Combination; Erythromycin; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Oxazoles; Oxazolidinones; Quinolines; Streptococcus; Virginiamycin | 2000 |
Comparison of the in vitro activity of pristinamycin and quinupristin/dalfopristin against Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Erythromycin; Microbial Sensitivity Tests; Penicillin G; Streptococcus pneumoniae; Virginiamycin | 2000 |
In vitro activity of quinupristin/dalfopristin in comparison with five antibiotics against worldwide clinical isolates of staphylococci.
Topics: Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Synergism; Drug Therapy, Combination; Erythromycin; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus; Vancomycin Resistance; Virginiamycin | 2000 |
Antibiotic resistance rates and macrolide resistance phenotypes of viridans group streptococci from the oropharynx of healthy Greek children.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Child; Child, Preschool; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Female; Fluoroquinolones; Greece; Humans; Infant; Male; Microbial Sensitivity Tests; Oropharynx; Phenotype; Rifampin; Streptococcus; Tetracycline; Vancomycin; Virginiamycin | 2001 |
In vivo efficacy of the new ketolide telithromycin (HMR 3647) in murine infection models.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Area Under Curve; Bacterial Infections; Biological Availability; Erythromycin; Half-Life; Injections, Intravenous; Ketolides; Macrolides; Male; Mice; Microbial Sensitivity Tests; Virginiamycin | 2001 |
Macrolide resistance in Streptococcus pyogenes isolates from throat infections in the region of Aachen, Germany.
Topics: Anti-Bacterial Agents; Drug Resistance; Erythromycin; Genotype; Germany; Ketolides; Macrolides; Microbial Sensitivity Tests; Pharynx; Phenotype; Polymorphism, Restriction Fragment Length; Regulon; Respiratory Tract Infections; Reverse Transcriptase Polymerase Chain Reaction; Streptococcal Infections; Streptococcus pyogenes; Streptogramins; Virginiamycin | 2001 |
In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms.
Topics: Anti-Bacterial Agents; Clindamycin; Drug Resistance, Microbial; Erythromycin; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Spain; Streptococcus pneumoniae; Virginiamycin | 2001 |
Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities
Topics: 4-Quinolones; Acetamides; Aminoglycosides; Anti-Bacterial Agents; Aza Compounds; Erythromycin; Fluoroquinolones; Gatifloxacin; Humans; Hydrogen-Ion Concentration; Ketolides; Linezolid; Macrolides; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Mycoplasma hominis; Mycoplasma pneumoniae; Oxazolidinones; Quinolines; Tetracyclines; Tigecycline; Ureaplasma urealyticum; Virginiamycin | 2001 |
Activity of quinupristin-dalfopristin in invasive isolates of Streptococcus pneumoniae from Italy.
Topics: Anti-Bacterial Agents; Clindamycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Electrophoresis, Agar Gel; Erythromycin; Humans; Italy; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pneumococcal Infections; Polymerase Chain Reaction; Streptococcus pneumoniae; Virginiamycin | 2001 |
In vitro activities of a new ketolide, ABT-773, against multidrug-resistant gram-positive cocci.
Topics: Anti-Bacterial Agents; Clindamycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Erythromycin; Gram-Positive Cocci; Ketolides; Microbial Sensitivity Tests; Virginiamycin | 2001 |
Molecular characterization of ketolide-resistant erm(A)-carrying Staphylococcus aureus isolates selected in vitro by telithromycin, ABT-773, quinupristin and clindamycin.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Clindamycin; DNA Transposable Elements; Drug Resistance, Bacterial; Erythromycin; Ketolides; Macrolides; Methyltransferases; Mutation; Staphylococcus aureus; Virginiamycin | 2002 |
Molecular analysis of constitutively expressed erm(C) genes selected in vitro by incubation in the presence of the noninducers quinupristin, telithromycin, or ABT-773.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Erythromycin; Genes, Bacterial; In Vitro Techniques; Ketolides; Macrolides; Microbial Sensitivity Tests; Mutation; Protein Biosynthesis; Selection, Genetic; Staphylococcus aureus; Virginiamycin | 2002 |
Comparative in vitro activity of quinupristin/dalfopristin and seven other antimicrobials against methicillin-susceptible and methicillin-resistant nosocomial Staphylococcus aureus bloodstream isolates.
Topics: Anti-Bacterial Agents; Bacteremia; Clindamycin; Cross Infection; Erythromycin; Gentamicins; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin; Virginiamycin | 2002 |
Comparative activity of linezolid, quinupristin-dalfopristin and newer quinolones against Streptococcus pneumoniae.
Topics: Acetamides; Anti-Infective Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Erythromycin; Humans; In Vitro Techniques; Linezolid; Oxazolidinones; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae; Virginiamycin | 2003 |
Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: SMART Program 2001 Data.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Erythromycin; Genes, Bacterial; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Phenotype; Streptococcal Infections; Streptococcus pyogenes; Taiwan; Virginiamycin | 2003 |
[BACTERIOSTATIC AND BACTERICIDAL INTERACTIONS IN ANTIBIOTICS OF THE STREPTOGRAMIN GROUP].
Topics: Anti-Bacterial Agents; Chloramphenicol; Drug Resistance, Microbial; Drug Synergism; Erythromycin; Immunodiffusion; Oxacillin; Penicillins; Pharmacology; Research; Spiramycin; Staphylococcus; Streptogramins; Streptomyces; Virginiamycin | 1964 |
Sequence and genetic organization of the 19.3-kb erythromycin- and dalfopristin-resistance plasmid pLME300 from Lactobacillus fermentum ROT1.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; DNA Replication; DNA Restriction-Modification Enzymes; Drug Resistance, Multiple, Bacterial; Enterococcus; Erythromycin; Food Chain; Gene Order; Lactobacillus; Molecular Sequence Data; Open Reading Frames; Plasmids; Replication Origin; Sequence Analysis, DNA; Virginiamycin | 2003 |
Relations between the consumption of antimicrobial growth promoters and the occurrence of resistance among Enterococcus faecium isolated from broilers.
Topics: Animal Feed; Animal Husbandry; Animals; Anti-Bacterial Agents; Chickens; Denmark; Drug Administration Schedule; Drug Resistance, Bacterial; Enterococcus faecium; Erythromycin; Gram-Positive Bacterial Infections; Linear Models; Logistic Models; Markov Chains; Microbial Sensitivity Tests; Monte Carlo Method; Oligosaccharides; Poultry Diseases; Time Factors; Vancomycin; Virginiamycin | 2004 |
Macrolide resistance phenotypes of commensal viridans group streptococci and Gemella spp. and PCR detection of resistance genes.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance; Erythromycin; Genes, Bacterial; Humans; Ketolides; Lincosamides; Linezolid; Macrolides; Membrane Proteins; Methyltransferases; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcaceae; Streptogramin B; Tetracycline Resistance; Virginiamycin; Viridans Streptococci | 2004 |
Airborne multidrug-resistant bacteria isolated from a concentrated swine feeding operation.
Topics: Air Microbiology; Animal Husbandry; Animals; Anti-Bacterial Agents; Clindamycin; Drug Resistance, Bacterial; Enterococcus; Environmental Monitoring; Erythromycin; Inhalation Exposure; Microbial Sensitivity Tests; Mid-Atlantic Region; Staphylococcus; Swine; Tetracycline; Vancomycin; Virginiamycin; Viridans Streptococci | 2005 |
Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance.
Topics: Anti-Bacterial Agents; Azithromycin; Binding Sites; Clindamycin; Crystallography; Drug Resistance, Bacterial; Erythromycin; Escherichia coli; Haloarcula marismortui; Ketolides; Mutation; Protein Binding; Ribosomes; RNA, Ribosomal, 23S; Virginiamycin | 2005 |
Incidence of inducible clindamycin resistance in staphylococci: first results from Turkey.
Topics: Anti-Bacterial Agents; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Turkey; Virginiamycin | 2005 |
The in vitro effects of quinupristin/dalfopristin, erythromycin and levofloxacin at low concentrations on the expression of different cell adhesion molecules on the surface of endothelial cells (Eahy926).
Topics: Anti-Bacterial Agents; Cell Adhesion Molecules; Cell Line; Dose-Response Relationship, Drug; Endothelial Cells; Erythromycin; Flow Cytometry; Humans; Levofloxacin; Ofloxacin; Phlebitis; Virginiamycin | 2006 |
Sampling the antibiotic resistome.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Ciprofloxacin; Daptomycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Genes, Bacterial; Ketolides; Macrolides; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Rifampin; Soil Microbiology; Streptomyces; Trimethoprim Resistance; Vancomycin Resistance; Virginiamycin | 2006 |
Establishing the change in antibiotic resistance of Enterococcus faecium strains isolated from Dutch broilers by logistic regression and survival analysis.
Topics: Abattoirs; Animals; Anti-Bacterial Agents; Cecum; Chickens; Colony Count, Microbial; Drug Resistance, Bacterial; Enterococcus faecium; Erythromycin; Gram-Positive Bacterial Infections; Logistic Models; Microbial Sensitivity Tests; Netherlands; Odds Ratio; Poultry Diseases; Proportional Hazards Models; Reference Values; Survival Analysis; Virginiamycin | 2006 |
Quinupristin-dalfopristin nonsusceptibility in pneumococci from sickle cell disease patients.
Topics: Anemia, Sickle Cell; Anti-Bacterial Agents; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Humans; Microbial Sensitivity Tests; Phylogeny; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae; Virginiamycin | 2007 |
Effect of quinupristin/dalfopristin on 3T3 and Eahy926 cells in vitro in comparison to other antimicrobial agents with the potential to induce infusion phlebitis.
Topics: Animals; Anti-Bacterial Agents; BALB 3T3 Cells; Cell Survival; Dose-Response Relationship, Drug; Endothelial Cells; Erythromycin; Fibroblasts; Humans; Infusions, Intravenous; Inhibitory Concentration 50; Levofloxacin; Mice; No-Observed-Adverse-Effect Level; Ofloxacin; Phlebitis; Reproducibility of Results; Toxicity Tests; Virginiamycin | 2007 |
[MIC and MBC of quinupristin/dalfopristin of erythromycin-resistant MRSA strains isolated from clinical specimens].
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Erythromycin; Humans; Inhibitory Concentration 50; Methicillin Resistance; Microbial Sensitivity Tests; Species Specificity; Staphylococcus aureus; Virginiamycin | 2006 |
Activities of clindamycin, synercid, telithromycin, linezolid, and mupirocin against Gram-positive coccal strains resistant to erythromycin in Korea.
Topics: Acetamides; Anti-Bacterial Agents; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Ketolides; Korea; Linezolid; Microbial Sensitivity Tests; Mupirocin; Oxazolidinones; Virginiamycin | 2007 |
In vitro activity of telithromycin and quinupristin/dalfopristin against methicillin-resistant coagulase-negative staphylococci with defined resistance genotypes.
Topics: Anti-Bacterial Agents; Clindamycin; Coagulase; Drug Resistance, Bacterial; Erythromycin; Ketolides; Macrolides; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus; Streptogramin A; Streptogramin B; Virginiamycin | 2007 |
Characterization of antimicrobial resistance in Enterococcus spp. recovered from a commercial beef processing plant.
Topics: Animals; Cattle; Ciprofloxacin; Drug Resistance, Bacterial; Enterococcus; Erythromycin; Food Handling; Lincomycin; Meat; Microbial Sensitivity Tests; Random Amplified Polymorphic DNA Technique; Tetracycline Resistance; Virginiamycin | 2010 |
Continuous feeding of antimicrobial growth promoters to commercial swine during the growing/finishing phase does not modify faecal community erythromycin resistance or community structure.
Topics: Animal Feed; Animal Husbandry; Animals; Anti-Bacterial Agents; Bacteria; Bacterial Proteins; Colony Count, Microbial; Drug Resistance, Bacterial; Erythromycin; Feces; Methyltransferases; RNA, Ribosomal, 16S; Swine; Time Factors; Tylosin; Virginiamycin | 2011 |
Antibiotic resistance among cultured bacterial isolates from bioethanol fermentation facilities across the United States.
Topics: Anti-Bacterial Agents; Bacteria; DNA, Bacterial; Drug Resistance, Bacterial; Erythromycin; Ethanol; Fermentation; Genes, Bacterial; Industrial Microbiology; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Sequence Analysis, DNA; United States; Virginiamycin | 2014 |
Prevalence of macrolide, lincosamide, and streptogramin resistance among staphylococci in a tertiary care hospital in Athens, Greece.
Topics: Anti-Bacterial Agents; Clindamycin; Cross Infection; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Genes, Bacterial; Genotype; Greece; Hospitals, University; Humans; Microbial Sensitivity Tests; Prevalence; Staphylococcal Infections; Staphylococcus aureus; Streptogramin B; Tertiary Healthcare; Virginiamycin | 2015 |
Mobile elements and chromosomal changes associated with MLS resistance phenotypes of invasive pneumococci recovered in the United States.
Topics: Anti-Bacterial Agents; Chromosomes, Bacterial; Drug Resistance, Multiple, Bacterial; Erythromycin; Genes, Bacterial; Humans; Interspersed Repetitive Sequences; Lincosamides; Macrolides; Microbial Sensitivity Tests; Phenotype; Pneumococcal Infections; Streptococcus pneumoniae; Streptogramins; United States; Virginiamycin | 2015 |
Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clindamycin; Dibekacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fusidic Acid; Gentamicins; Humans; Infant; Infant, Newborn; Ketolides; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Mupirocin; Oxacillin; Republic of Korea; Retrospective Studies; Rifampin; Staphylococcal Skin Infections; Staphylococcus aureus; Teicoplanin; Tetracycline; Vancomycin; Virginiamycin; Young Adult | 2016 |
An LC-MS/MS method for the determination of antibiotic residues in distillers grains.
Topics: Acetonitriles; Animal Feed; Animals; Anti-Bacterial Agents; Chromatography, Liquid; Edible Grain; Erythromycin; Hexanes; Limit of Detection; Penicillin G; Solid Phase Extraction; Streptogramin A; Streptogramin Group B; Tandem Mass Spectrometry; Virginiamycin | 2017 |
Effects of low concentrations of erythromycin, penicillin, and virginiamycin on bacterial resistance development in vitro.
Topics: Anti-Bacterial Agents; Campylobacter; Drug Resistance, Bacterial; Enterococcus; Erythromycin; Mutation Rate; Penicillins; Selection, Genetic; Virginiamycin | 2017 |
Clinical and molecular features of MDR livestock-associated MRSA ST9 with staphylococcal cassette chromosome mecXII in humans.
Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Child, Preschool; Ciprofloxacin; Clindamycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Farmers; Female; Gentamicins; Humans; Livestock; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Minocycline; Staphylococcal Infections; Swine; Swine Diseases; Taiwan; Tigecycline; Virginiamycin | 2018 |
Expression of resistance genes instead of gene abundance are correlated with trace levels of antibiotics in urban surface waters.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Environmental Monitoring; Erythromycin; Genes, Microbial; In Situ Hybridization, Fluorescence; Lincosamides; Macrolides; Microbial Sensitivity Tests; Streptogramin B; Streptogramin Group B; Virginiamycin; Water Microbiology; Water Pollutants, Chemical | 2019 |
In vitro synergistic effect of retapamulin with erythromycin and quinupristin against Enterococcus faecalis.
Topics: Anti-Bacterial Agents; Bridged Bicyclo Compounds, Heterocyclic; Diterpenes; Drug Synergism; Enterococcus faecalis; Enterococcus faecium; Erythromycin; Gram-Positive Bacterial Infections; Humans; Macrolides; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus pyogenes; Virginiamycin | 2020 |